Showing results (1-10 of 124) with videos related to
Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|February 28, 2019
Eligibility criteria for phase I clinical trials: tight vs loose?Laeeq Malik, David LuInvestigational New Drugs|November 17, 2018
Increasing complexity in oncology phase I clinical trialsLaeeq Malik, David LuCancer Chemotherapy and Pharmacology|August 29, 2018
A comparison of the quality of informed consent for phase I oncology trials over a 30-year periodLaeeq Malik, James CooperWorld Journal of Oncology|November 18, 2017
Advanced Thyroid Cancer Patients in Phase I Clinical Trials: Outcome Assessment and Literature ReviewLaeeq Malik, Alex MejiaJournal of Clinical Medicine Research|April 16, 2014
Informed consent for phase I oncology trials: form, substance and signatureLaeeq Malik, Alex MejiaCancer Reports (Hoboken, N.J.)|August 9, 2020
Association between tyrosine-kinase inhibitor induced hypertension and treatment outcomes in metastatic renal cancerMonique Gadd, Ganes Pranavan, Laeeq MalikCancer Chemotherapy and Pharmacology|January 26, 2018
Role of immunotherapy in bladder cancer: past, present and futureSabeeh-Ur-Rehman Butt, Laeeq MalikCancer Chemotherapy and Pharmacology|July 20, 2018
A phase I pharmacokinetic and pharmacodynamic study of GTI-2040 in combination with gemcitabine in patients with solid tumorsLaeeq Malik, Anthony Zwiebel, James CooperEuropean Journal of Cancer (Oxford, England : 1990)|September 22, 2014
Eligibility of patients with renal impairment for Phase I trials: Time for a rethink?Laeeq Malik, Alex Mejia, Steven WeitmanCancer Investigation|October 14, 2015
Advanced Cancer Patients' Understanding and Perceptions of Phase I Clinical TrialsJamie Pawlowski, Laeeq Malik, Devalingam MahalingamPageof 13